New Delhi [India], July 25 (ANI): MenFive, the first conjugate vaccine to protect against the five predominant causes of meningococcal meningitis in Africa, has been prequalified by the World Health Organization (WHO)According to Adar Poonawalla, CEO, Serum Institute of India, MenFive is a game changer vaccine, "MenFive is a game-changer vaccine developed through a powerful 13-year collaboration between Serum Institute of
